Clinical impact of structured follow-up after pancreatic surgery

ObjectivesStructured follow-up after surgery for pancreatic ductal adenocarcinoma (PDAC) remains controversial and is currently not recommended due to a supposed lack of therapeutic consequences. Furthermore, it is not clear whether noncancer patients after pancreas resection need to be seen in the

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Tjaden, Christin (VerfasserIn) , Michalski, Christoph (VerfasserIn) , Strobel, Oliver (VerfasserIn) , Giese, Nathalia (VerfasserIn) , Hennche, Anne-Kathrin (VerfasserIn) , Büchler, Markus W. (VerfasserIn) , Hackert, Thilo (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: [July 2016]
In: Pancreas
Year: 2016, Jahrgang: 45, Heft: 6, Pages: 895-899
ISSN:1536-4828
DOI:10.1097/MPA.0000000000000564
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/MPA.0000000000000564
Volltext
Verfasserangaben:Christine Tjaden, MC, Christoph Michalski, MC, Oliver Strobel, MD, Nathalia Giese, MD, Anne-Kathrin Hennche, Markus Büchler, MD, and Thilo Hackert, MD
Beschreibung
Zusammenfassung:ObjectivesStructured follow-up after surgery for pancreatic ductal adenocarcinoma (PDAC) remains controversial and is currently not recommended due to a supposed lack of therapeutic consequences. Furthermore, it is not clear whether noncancer patients after pancreas resection need to be seen in the
Beschreibung:Gesehen am 27.05.2020
Beschreibung:Online Resource
ISSN:1536-4828
DOI:10.1097/MPA.0000000000000564